Communiqués Atara Biotherapeutics, Inc.

Actions

ATRA

US0465132068

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq 22:00:00 07/10/2026			Varia. 5j.	Varia. 1 janv.
9,370 ^USD	-3,90%		+10,24%	-48,20%

12/08	Atara Biotherapeutics, Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
26/06	Atara Biotherapeutics, Inc. annonce des changements au sein de sa direction	CI

Communiqués

30/09	Atara Biotherapeutics Reports that the Tabelecleucel Biologics License Application Has Been Resubmitted to the U.S. Food and Drug Administration	BU
12/08	Atara Biotherapeutics: Q2 Earnings Snapshot	AQ
12/08	Atara Biotherapeutics Announces Second Quarter 2026 Financial Results and Operational Progress	BU
12/06	Atara Biotherapeutics Announces Changes to Its Board of Directors	BU
20/05	DEADLINE ALERT: Atara Biotherapeutics (ATRA) Investors Who Suffered Losses Encouraged to Contact Faruqi & Faruqi Before May 22, 2026 Securities Class Action Deadline	NE
19/05	ATRA INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026	NE
17/05	ATRA DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026	NE
15/05	ATRA UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026	NE
13/05	ATRA CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026	NE
12/05	Atara Biotherapeutics: Q1 Earnings Snapshot	AQ
12/05	Atara Biotherapeutics : Quarterly Report for Quarter Ending March 31 2026 (Form 10-Q)	PU
12/05	Atara Biotherapeutics Announces First Quarter 2026 Financial Results and Operational Progress	BU
12/05	ATRA SHAREHOLDER RIGHTS ALERT: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026	NE
09/05	ATRA INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026	NE
07/05	ATRA CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026	NE
07/05	Atara Biotherapeutics Provides Regulatory Update on Tabelecleucel	BU
04/05	ATRA INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026	NE
03/05	ATRA Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026	NE
29/04	ATRA UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026	NE
25/04	ATRA INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026	NE
24/04	ATRA Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026	NE
20/04	ATRA UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026	NE
18/04	ATRA CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026	NE
14/04	ATRA DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026	NE
13/04	Faruqi & Faruqi, LLP Highlights Class Action Against Atara (ATRA) and Upcoming Lead Plaintiff Deadline of May 22, 2026	NE